Chemoinformaics analysis of 2,4,6-Octatriene, 3,4-dimethyl-
| Molecular Weight | 136.238 | nRot | 2 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 3 |
| Exact Molecular Weight | 136.125 | nRing | 0 |
| Solubility: LogS | -3.183 | nHRing | 0 |
| Solubility: LogP | 2.574 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.3687 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.51 |
| Synth | 3.395 |
| Natural Product Likeliness | 1.922 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.164 |
| MDCK | 0.0000295 |
| BBB | 0.505 |
| PPB | 0.928922 |
| VDSS | 2.784 |
| FU | 0.122996 |
| CYP1A2-inh | 0.958 |
| CYP1A2-sub | 0.957 |
| CYP2c19-inh | 0.504 |
| CYP2c19-sub | 0.901 |
| CYP2c9-inh | 0.091 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.781 |
| CYP2d6-sub | 0.896 |
| CYP3a4-inh | 0.047 |
| CYP3a4-sub | 0.376 |
| CL | 8.119 |
| T12 | 0.503 |
| hERG | 0.012 |
| Ames | 0.013 |
| ROA | 0.018 |
| SkinSen | 0.672 |
| Carcinogencity | 0.15 |
| EI | 0.989 |
| Respiratory | 0.719 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.941956 |